HER2-overexpression and amplification is reported in esophageal cancer with a tendency towards higher rates of positivity in adenocarcinoma [5]–[10] compared to squamous cell carcinomas [6], [7], [11]–[13]. The gene discussed is ERBB2; the disease is esophageal cancer.